fromFast Company
11 hours agoA new contender just rattled the obesity drug market
According to a Sept. 16 press release, three separate doses of the new drug (6 mg, 12 mg, and 36 mg) demonstrated "significant improvements" in body weight reduction compared to a placebo at 72 weeks. "Obesity is a complex, global health challenge - and patients need treatment options that are both effective and easy to integrate into everyday life," Sean Wharton, M.D., director at Wharton Medical Clinic and lead investigator, said in the release.
Medicine